Wells Fargo & Company »

Aileron Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aileron Therapeutics (ALRN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $206 31 6.67
2023-12-31 $81 27 3.04
2023-09-30 $36 24 1.50
2023-06-30 $43 24 1.79
2022-12-31 $54 23 2.39